Our aim is to identify, evaluate and support the most innovative developments in eye care, throughout licensing agreements and/or equity investments.
In addition of our funding to support the R&D phases to reach proof of concept in human, Théa offers the expertise and capabilities to develop and commercialize innovative therapeutic solutions in Ophthalmology, in order to provide patients and healthcare professionals with tomorrow’s solutions.
We work through alliance management. Our partners retain their specific expertise in house and remain leader of their project while they will benefit from Théa’s know how in ophthalmology and funding.
Small & medium-sized companies, startups, young innovative companies, researchers or academics can team up with Théa Open Innovation to offer tomorrow’s solutions to eye-care practitioners and their patients.